Intuitive Surgical stock trades 28% below target despite strong business and growth prospects.

Intuitive Surgical's stock is down 34% year-to-date, trading at $373.71 versus an average Wall Street target of $477.25, reflecting a 28% discount. The decline followed slower-than-expected growth guidance and tariff pressures, but the company continues to beat earnings and revenue estimates, driven by its da Vinci surgical system upgrade cycle. Analysts remain bullish, citing strong margins, recurring revenue, and a large cash position, with most rating the stock as a buy or strong buy. The stock's drop appears excessive compared to peers, suggesting potential upside if growth stabilizes and tariff impacts remain contained.